Which statement is not associated with the enzyme-multiplied immunoassay technique (EMIT)?

Which statement is not associated with the enzyme-multiplied immunoassay technique (EMIT)?

• A. It is a homogeneous enzyme immunoassay
• B. Determines antigen concentration
• C. Employs a labeled reactant
• D. Enzyme reacts with drug in serum sample

Answer: (D)

EMIT is a homogeneous competitive immunoassay that uses an enzyme-labeled drug as a tracer. The toxin or drug in the patient’s sample competes with the labeled drug for binding to a specific antibody. Because the readout depends on the enzyme activity of the labeled tracer, the assay quantifies how much unlabeled drug is present in the sample without any separation step. This approach inherently determines the drug concentration (the antigen) and relies on a labeled reactant to generate a measurable signal. The idea that the enzyme must react directly with the drug in the serum isn’t part of EMIT; there isn’t a direct enzymatic reaction between the enzyme label and the drug in the sample—the signal comes from the binding interactions that alter enzyme activity of the tracer.

EMIT is a homogeneous competitive immunoassay that uses an enzyme-labeled drug as a tracer. The toxin or drug in the patient’s sample competes with the labeled drug for binding to a specific antibody. Because the readout depends on the enzyme activity of the labeled tracer, the assay quantifies how much unlabeled drug is present in the sample without any separation step. This approach inherently determines the drug concentration (the antigen) and relies on a labeled reactant to generate a measurable signal. The idea that the enzyme must react directly with the drug in the serum isn’t part of EMIT; there isn’t a direct enzymatic reaction between the enzyme label and the drug in the sample—the signal comes from the binding interactions that alter enzyme activity of the tracer.